Diabetes pharmacology Flashcards
Mechanisms of insulin therapy
Insulin binds to tyrosine kinase receptors where it initiates 2 pathways by phosphorylation:
MAP kinase signalling pathway
PI-3K signalling pathway
What is the purpose of the MAP kinase signalling pathway (insulin therapy)
Responsible for cell growth a proliferation
What is the purpose of the PI-3K signalling pathway (insulin therapy)
Responsible for the transport of GLUT-4 receptors to the cell surface membrane
GLUT-4 transports glucose into the cell
This pathway is also responsible for protein, lipid and glycogen synthesis
Side-effects of insulin therapy
Weight gain
Hypoglycaemia
Localised lipoatrophy
Hypokalemia
Contraindications of insulin
Hypersensitivity to any of ingredients of therapy
Hypoglycaemia
Drug interactions
Thiazide diuretics (decrease effect of insulin)
Corticosteroids
Repaglinide
Monoamine oxidase inhibitors
Levothyroxine (decreases effect of insulin)
Example of biguanide
Metformin
Mechanisms of metformin/biguanide action
Increased peripheral insulin sensitivity
Increased glucose uptake into and use by skeletal muscle
Decreased hepatic gluconeogenesis
Decreased intestinal glucose absorption
Other use of Metformin, other than type 2 diabetes
Polycystic ovarian syndrome
Side effects of metformin
GI tract disturbance e.g. diarrhoea
N/V
Lactic acidosis
Contraindications of metformin
Renal failure
Cardiac failure
Respiratory failure
Hepatic failure
Drug Interactions of metformin
Contrast agents
ACE inhibitors
NSAIDs
Steroids
Example of sulphonylurea
Glipzide
Mechanism of sulphonylurea action
Stimulates release of insulin by blocking potassium channels on pancreatic beta cells
Side effects of sulphonylurea
GI disturbance
Hypoglycaemia
Weight gain